Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02058498 · ClinicalTrials.gov registry record · NA

Increasing Activity in Liver Transplant Patients

A NA study of Liver Transplant, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT02058498: Completed NA study of Liver Transplant, sponsored by Mayo Clinic.

NCT02058498 is a NA study of Liver Transplant that has completed, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 5,458-participant average among 19 other Liver Transplant trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02058498, a NA study of Liver Transplant, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Will adult liver transplant patients who are provided with physical activity (walking) instructions increase their physical activity and perceive an improved quality of life?

Primary Outcome

The IPAQ calculates the metabolic equivalent (MET) score by asking participants the days and minutes exercised in three categories of intensity (vigorous, moderate, and walking) during the previous one week. The following formula is used to calculate the MET: MET=8(vigorous activity) (minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes).

Conditions Studied

Interventions

  • BEHAVIORAL Physical activity

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2014-02
Est. Completion 2014-12
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02058498 record still lists

NCT02058498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 5,458-participant average among 19 other Liver Transplant trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which Physical activity is the first listed.

NCT02058498 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02058498 about?

NCT02058498 is a clinical study titled "Increasing Activity in Liver Transplant Patients". Will adult liver transplant patients who are provided with physical activity (walking) instructions increase their physical activity and perceive an improved quality of life?

What is the current status of trial NCT02058498?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-02. Estimated completion is 2014-12.

What conditions does trial NCT02058498 study?

This clinical trial studies the following conditions: Liver Transplant.

What interventions are being tested in trial NCT02058498?

The interventions under investigation include: Physical activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT02058498?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02058498 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02058498's enrollment target sits among peer trials

12 19th of 19 higher than 1 of 19 other Liver Transplant trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Liver Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02058498, the US trial registry maintained by the National Library of Medicine. NCT02058498 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.